{"id":"W2995067257","doi":"10.1016/j.jval.2019.09.2663","title":"PSY35 A COMPARATIVE ANALYSIS OF HEALTH TECHNOLOGY ASSESSMENTS EVALUATING RECENTLY APPROVED BIOLOGICAL THERAPIES FOR ADULT PATIENTS WITH MODERATE-TO-SEVERE PSORIASIS IN THE US, CANADA AND UK","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"","keywords":"Medicine; Ixekizumab; Discontinuation; Psoriasis; Pharmacoeconomics; Population; Clinical trial; Regimen; Intensive care medicine; Internal medicine; Psoriatic arthritis; Dermatology; Secukinumab; Environmental health","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.009305673,0.0005091383,0.001825651,0.002222807,0.0003973368,0.001760599,0.0006523242,0.0007845594,0.003472979],"category_scores_gemma":[0.04492296,0.0002455419,0.005621718,0.004628257,0.0004767451,0.001133074,0.001192813,0.001586885,0.0001801834],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.009054798,"about_ca_system_score_gemma":0.005707561,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.3131377,"about_ca_topic_score_gemma":0.2741238,"domain_scores_codex":[0.9883306,0.006308152,0.001453128,0.0006573866,0.002569728,0.0006809647],"domain_scores_gemma":[0.9691956,0.01932066,0.004582541,0.0007187549,0.005027079,0.001155276],"domain_codex":null,"domain_gemma":"evaluation","domain_candidate":"evaluation","domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"systematic_review","study_design_scores_codex":[0.1099489,0.0004280889,0.6870371,0.005849515,0.05016585,0.0003641718,0.0009581034,0.01416768,0.000679795,0.003072968,0.01055059,0.1167773],"study_design_scores_gemma":[0.002039911,0.002652093,0.9793785,0.0005530365,0.006479877,0.0001775764,0.000496678,0.004167585,0.0001673921,0.0002896439,0.003514754,0.00008295507],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9232196,0.04650286,0.0008822971,0.001294947,0.0001309247,0.0003028159,0.02166411,0.00002989627,0.005972515],"genre_scores_gemma":[0.9923447,0.001736988,0.0002579603,0.0001067327,0.00003107169,0.00005313289,0.005100646,0.000005153606,0.0003637008],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9909452,"threshold_uncertainty_score":0.62263,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3489291710632158,"score_gpt":0.4426431649484158,"score_spread":0.09371399388519996,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}